People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LivFul Inc. | — | Pharmaceuticals | Series A | $10.1M | $676K | 2024 |
Kevin Engel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Engel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| MICHAEL NORMAN | 1 | 4 |
| ANDREW BARLOW | 1 | 3 |
| Francis Yip | 1 | 1 |
| Matt Elsberry | 1 | 1 |
| Hogan Bassey | 1 | 1 |
| John Manwell | 1 | 1 |
| Yaw Nsarkoh | 1 | 1 |
| Kris Maynard | 1 | 1 |
| Carl Thong | 1 | 1 |
| Wesley Lyons | 1 | 1 |
| Dave Rae | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.